TOM Medications
Enabling the future of personalized healthcare with patient-generated insights.
Enabling the future of personalized healthcare with patient-generated insights.
TOM Medications
Slogan: Enabling the future of personalized healthcare with patient-generated insights.
Description: Personalized health needs patient insights. Most of a patient's journey remains unobserved and hidden in unknowledge, for both patients and healthcare providers. TOM sheds light on the dark and generates knowledge about the therapeutic process. With millions of proprietary, patient-generated data. The TOM App boasts world-class patient engagement, fostering behavior change and adherence for superior therapy outcomes.
Founded: 2020
Industries: Health Care
Headquarter: Switzerland
Last Investment: Fr.1.30MCorporate Round investment at 25 January 2023
Last Investment Investors: Galenica
TOM Medications, a Switzerland-based startup founded in 2020, is revolutionizing personalized healthcare by leveraging patient-generated insights. Their TOM App is designed to uncover and harness patient data, shedding light on the therapeutic process and improving therapy outcomes. The company recently secured a Fr.1.30MCorporate Round investment from Galenica on 25 January 2023, signaling investor confidence in their innovative approach to personalized health. With a focus on patient engagement and behavior change, TOM Medications is poised to make a significant impact in the healthcare industry.| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Corporate Round | Fr.1.30M | 1 | Galenica | 25 Jan 2023 |
| Seed Round | $2.30M | 2 | Sanitas Disruptive, Galenica | 10 Sep 2021 |
| Pre Seed Round | Fr.900.00K | - | 01 Feb 2020 | |
| Pre Seed Round | Fr.110.00K | - | 22 Mar 2019 |
No recent news or press coverage available for TOM Medications.
We care about your data, and we'd love to use cookies make your experience better.
